Treatment with IL30 also upregulated tumor progression genes, such as Ar (3.27 times), Bcl2 (3.25 times), IL6 (3.90 times), Cav2 (7.60 times), Ndrg3 (4.5 times), Sept7 (4.10 times) and Sfrp1 (7.46 times) (Fig. 2A). The gene discussed is BCL2; the disease is neoplasm.